The total lifetime health cost savings of smoking cessation to society
- PMID: 16014659
- DOI: 10.1093/eurpub/cki024
The total lifetime health cost savings of smoking cessation to society
Abstract
Background: Smoking cessation has major immediate and long-term health benefits. However, ex-smokers' total lifetime health costs and continuing smokers' costs remain uncompared, and hence the economic savings of smoking cessation to society have not been determined.
Methods: The economic effects of smoking cessation in a lifetime perspective have been examined by comparing the health costs of continuing smokers and ex-smokers by quantity of daily tobacco consumption, age, gender and disease group, while taking differences in life expectancy and the reductions in relative risks after cessation into account.
Results: The total lifetime health cost savings of smoking cessation are highest at the younger ages. Although the economic savings vary with age at quitting, gender and quantity of daily tobacco consumption, all ex-smoking men and women who quit smoking at the age of 35 to 55 years generate sizeable total lifetime cost savings. At older ages, the total lifetime health cost savings of smoking cessation are of little economic consequence to the society. The total, direct and productivity lifetime cost savings of smoking cessation in moderate smokers who quit smoking at the age of 35 years are 24,800 euros, 7600 euros, and 17,200 euros in men, and 34,100 euros, 12,200 euros, and 21,800 euros in women, respectively.
Conclusions: Lifetime health cost savings of smoking cessation to society are substantial at younger ages, in terms of both direct and productivity costs.
Similar articles
-
The health care costs of smoking.N Engl J Med. 1997 Oct 9;337(15):1052-7. doi: 10.1056/NEJM199710093371506. N Engl J Med. 1997. PMID: 9321534
-
Changes in health care costs before and after smoking cessation.Nicotine Tob Res. 2006 Jun;8(3):393-401. doi: 10.1080/14622200600670314. Nicotine Tob Res. 2006. PMID: 16801297
-
A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.Tob Control. 2008 Jun;17(3):177-82. doi: 10.1136/tc.2007.022368. Epub 2008 Feb 19. Tob Control. 2008. PMID: 18285385
-
Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?Expert Rev Pharmacoecon Outcomes Res. 2009 Jun;9(3):257-64. doi: 10.1586/erp.09.28. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19527098 Review.
-
The costs of smoking and the cost effectiveness of smoking-cessation programs.J Public Health Policy. 1990 Summer;11(2):218-37. J Public Health Policy. 1990. PMID: 2114423 Review.
Cited by
-
Indoor smoking bans in Bulgaria, Croatia, Northern Cyprus, Romania and Turkey.Tob Control. 2010 Oct;19(5):417-20. doi: 10.1136/tc.2009.029769. Epub 2010 Jul 30. Tob Control. 2010. PMID: 20675690 Free PMC article.
-
Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis.Drug Saf. 2011 Mar 1;34(3):199-210. doi: 10.2165/11585950-000000000-00000. Drug Saf. 2011. PMID: 21332244
-
Smoking Cessation Is Associated With Lower Indirect Costs.J Occup Environ Med. 2018 Jun;60(6):490-495. doi: 10.1097/JOM.0000000000001302. J Occup Environ Med. 2018. PMID: 29465514 Free PMC article.
-
Modeling lifetime costs and health outcomes attributable to secondhand smoke exposure at home among Korean adult women.BMJ Open. 2017 May 17;7(5):e013292. doi: 10.1136/bmjopen-2016-013292. BMJ Open. 2017. PMID: 28515183 Free PMC article.
-
Narrative review of genes, environment, and cigarettes.Ann Med. 2016 Aug;48(5):337-51. doi: 10.1080/07853890.2016.1177196. Epub 2016 Apr 28. Ann Med. 2016. PMID: 27124093 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical